The role of complement components in traumatic brain injury is poorly understood. Here we show that secondary damage after acute cryoinjury is significantly reduced in C3 À / À or C5 À / À mice or in mice treated with C5a receptor antagonist peptides. Injury sizes and neutrophil extravasation were compared. While neutrophil density increased following traumatic brain injury in wild type (C57BL/6) mice, C3-deficient mice demonstrated lower neutrophil extravasation and injury sizes in the brain. RNase protection assay indicated that C3 contributes to the induction of brain inflammatory mediators, MIF, RANTES (CCL5) and MCP-1 (CCL2). Intracranial C3 injection induced neutrophil extravasation in injured brains of C3 À / À mice suggesting locally produced C3 is important in brain inflammation. We show that neutrophil extravasation is significantly reduced in both C5
Introduction
The complement system is a protein cascade involved in the innate immune response. Complement components have been implicated in exacerbation of inflammatory injury in several different tissues, including the central nervous system (CNS). Within the CNS, complement has been shown to be involved in traumatic brain injury using several animal models as well as studying human trauma patients (Stahel et al., 2001) . It was suggested that the complement system might contribute to secondary damage caused by inflammation of the CNS. The magnitude and mechanism of this contribution have yet to be elucidated, due in part to the multifunctionality of the complement system. Possible results of complement activation in the CNS that might contribute to inflammatory damage include opsonization and phagocytosis via C3b deposition, recruitment and activation of immune cells, especially neutrophils, from the peripheral blood by the C5a anaphylatoxin, and direct destruction of tissue by formation of pore-forming membrane attack complexes (MAC) leading to further inflammation. All of these mechanisms have been suggested to play a role in CNS inflammatory diseases and trauma. For example, experimentally induced global ischemia affects the biosynthesis of C1q, the recognition subcomponent of the classical complement activation pathway, in the CNS (Schafer et al., 2000) . Rancan et al. (2003) has shown that transgenic mice with astrocyte targeted expression of the soluble complement inhibitor sCrry have reduced neurologic impairment and more normal blood -brain barrier function following closed head injury compared with wild type C57BL/6 control littermates. Studies suggest that elevated levels of complement proteins in CSF of patients with severe traumatic brain injury may contribute to secondary damage, (Kossmann et al., 1997) and it has
